About this trial
This is a multicenter, prospective, observational, community-based study designed to evaluate the incidence of respiratory syncytial virus (RSV) infection among community-dwelling elderly individuals in China, as well as their cohabiting older adults and children, over a 24-month period. During the study, home visits will be conducted to collect nasopharyngeal (NP) swabs from all community residents aged ≥50 years who report symptoms of acute respiratory infection (ARI). Pathogen detection will be performed using both point-of-care testing (POCT) and centralized laboratory analysis.
Eligibility criteria
Qualifiers
Male or female adults aged ≥50 years (calculated based on date of birth and date of visit).
At least two respiratory symptoms/signs within 48 hours prior to self-reporting OR
At least one respiratory symptom/sign + one systemic symptom/sign within 48 hours prior to self-reporting
Provision of written informed consent by the participant or their legal guardian, in accordance with local EC (Ethics Committee) requirements.
Disqualifiers
Enrollment in the CRE-ARI group within the preceding 14 days.
Enrollment in the CRE-ARI group has been more than 4 times during the previous 12 months (applicable only to the CRE-ARI group enrollment).
For CAI group, if a household has been enrolled into CAI group within the previous 12 months.
Residence outside the designated study catchment area.
Trial design
Treatments tested in this trial
- NP swabs
Treatment groups
Sponsors and collaborators
Huashan Hospital
Lead sponsor
Shanghai Huashen Institute of Microbes and Infections
Collaborator